US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist
  • 0.2102
  • +0.0202+10.63%
Trading Nov 21 13:10 ET
39.29MMarket Cap-2P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-29.26%2.82M
2.21M
2.48M
7.77M
3.78M
3.99M
0
0
0
0
Operating revenue
-29.26%2.82M
--2.21M
--2.48M
--7.77M
--3.78M
--3.99M
--0
--0
--0
--0
Cost of revenue
-34.50%1.56M
3.37M
1.66M
4.74M
2.37M
2.37M
0
0
0
0
Gross profit
-21.55%1.27M
-1.16M
822K
3.03M
1.41M
1.62M
0
0
0
0
Operating expense
-49.09%15.15M
-40.69%17.2M
-34.60%22.17M
8.31%121.41M
-12.18%28.74M
0.58%29.76M
24.28%29M
28.24%33.9M
21.43%112.09M
11.02%32.73M
Selling and administrative expenses
-11.54%7.71M
6.77%7.5M
25.96%9.31M
15.02%34.75M
44.29%11.62M
17.89%8.71M
3.98%7.03M
-7.77%7.39M
28.72%30.22M
12.13%8.05M
-General and administrative expense
----
6.77%7.5M
25.96%9.31M
15.02%34.75M
----
----
3.98%7.03M
-7.77%7.39M
28.72%30.22M
----
Research and development costs
-56.70%9.11M
-55.87%9.7M
-51.48%12.86M
5.84%86.66M
-30.62%17.12M
-5.18%21.05M
32.55%21.98M
43.91%26.51M
18.94%81.88M
10.67%24.67M
Other operating expenses
---1.67M
----
----
----
----
----
----
----
----
----
Operating profit
50.67%-13.89M
36.70%-18.36M
37.02%-21.35M
-5.61%-118.38M
16.50%-27.33M
4.88%-28.15M
-24.28%-29M
-28.24%-33.9M
-21.43%-112.09M
-11.02%-32.73M
Net non-operating interest income expense
Other net income (expense)
-290.12%-327K
-9,452.48%-60.42M
614.83%6.41M
-8.06%1.72M
7K
172K
646K
897K
1.87M
Gain on sale of security
----
---855K
--7.01M
----
----
----
----
----
----
----
Special income (charges)
--0
---58.96M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--58.96M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-290.12%-327K
-193.65%-605K
-166.11%-593K
-8.06%1.72M
--7K
--172K
--646K
--897K
--1.87M
----
Income before tax
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
-5.84%-116.66M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-19.43%-110.22M
-7.20%-31.68M
Income tax
Net income
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
-5.84%-116.66M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-19.43%-110.22M
-7.20%-31.68M
Net income continuous Operations
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
-5.84%-116.66M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-19.43%-110.22M
-7.20%-31.68M
Minority interest income
Net income attributable to the parent company
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
-5.84%-116.66M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-19.43%-110.22M
-7.20%-31.68M
Preferred stock dividends
6.66M
2.4M
Other preferred stock dividends
Net income attributable to common stockholders
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
0.19%-116.66M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-26.65%-116.88M
-15.33%-34.08M
Basic earnings per share
99.40%-0.23
60.84%-19.28
94.39%-5.76
65.77%-219.2
32.38%-75.73
71.53%-38.63
79.86%-49.23
68.10%-102.72
60.47%-640.32
75.00%-112
Diluted earnings per share
99.40%-0.23
60.84%-19.28
94.39%-5.76
65.77%-219.2
32.38%-75.73
71.53%-38.63
79.86%-49.23
68.10%-102.72
60.47%-640.32
75.00%-112
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -29.26%2.82M2.21M2.48M7.77M3.78M3.99M0000
Operating revenue -29.26%2.82M--2.21M--2.48M--7.77M--3.78M--3.99M--0--0--0--0
Cost of revenue -34.50%1.56M3.37M1.66M4.74M2.37M2.37M0000
Gross profit -21.55%1.27M-1.16M822K3.03M1.41M1.62M0000
Operating expense -49.09%15.15M-40.69%17.2M-34.60%22.17M8.31%121.41M-12.18%28.74M0.58%29.76M24.28%29M28.24%33.9M21.43%112.09M11.02%32.73M
Selling and administrative expenses -11.54%7.71M6.77%7.5M25.96%9.31M15.02%34.75M44.29%11.62M17.89%8.71M3.98%7.03M-7.77%7.39M28.72%30.22M12.13%8.05M
-General and administrative expense ----6.77%7.5M25.96%9.31M15.02%34.75M--------3.98%7.03M-7.77%7.39M28.72%30.22M----
Research and development costs -56.70%9.11M-55.87%9.7M-51.48%12.86M5.84%86.66M-30.62%17.12M-5.18%21.05M32.55%21.98M43.91%26.51M18.94%81.88M10.67%24.67M
Other operating expenses ---1.67M------------------------------------
Operating profit 50.67%-13.89M36.70%-18.36M37.02%-21.35M-5.61%-118.38M16.50%-27.33M4.88%-28.15M-24.28%-29M-28.24%-33.9M-21.43%-112.09M-11.02%-32.73M
Net non-operating interest income expense
Other net income (expense) -290.12%-327K-9,452.48%-60.42M614.83%6.41M-8.06%1.72M7K172K646K897K1.87M
Gain on sale of security -------855K--7.01M----------------------------
Special income (charges) --0---58.96M--------------0--0------------
-Less:Impairment of capital assets --0--58.96M--------------0--0------------
Other non- operating income (expenses) -290.12%-327K-193.65%-605K-166.11%-593K-8.06%1.72M--7K--172K--646K--897K--1.87M----
Income before tax 49.19%-14.21M-177.81%-78.78M54.74%-14.94M-5.84%-116.66M13.76%-27.32M3.47%-27.98M-22.54%-28.36M-24.94%-33.01M-19.43%-110.22M-7.20%-31.68M
Income tax
Net income 49.19%-14.21M-177.81%-78.78M54.74%-14.94M-5.84%-116.66M13.76%-27.32M3.47%-27.98M-22.54%-28.36M-24.94%-33.01M-19.43%-110.22M-7.20%-31.68M
Net income continuous Operations 49.19%-14.21M-177.81%-78.78M54.74%-14.94M-5.84%-116.66M13.76%-27.32M3.47%-27.98M-22.54%-28.36M-24.94%-33.01M-19.43%-110.22M-7.20%-31.68M
Minority interest income
Net income attributable to the parent company 49.19%-14.21M-177.81%-78.78M54.74%-14.94M-5.84%-116.66M13.76%-27.32M3.47%-27.98M-22.54%-28.36M-24.94%-33.01M-19.43%-110.22M-7.20%-31.68M
Preferred stock dividends 6.66M2.4M
Other preferred stock dividends
Net income attributable to common stockholders 49.19%-14.21M-177.81%-78.78M54.74%-14.94M0.19%-116.66M19.84%-27.32M3.47%-27.98M-3.51%-28.36M-24.94%-33.01M-26.65%-116.88M-15.33%-34.08M
Basic earnings per share 99.40%-0.2360.84%-19.2894.39%-5.7665.77%-219.232.38%-75.7371.53%-38.6379.86%-49.2368.10%-102.7260.47%-640.3275.00%-112
Diluted earnings per share 99.40%-0.2360.84%-19.2894.39%-5.7665.77%-219.232.38%-75.7371.53%-38.6379.86%-49.2368.10%-102.7260.47%-640.3275.00%-112
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+1.06%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.62%